Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment (Q46954312)
Jump to navigation
Jump to search
scientific article published on 11 October 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment |
scientific article published on 11 October 2007 |
Statements
1 reference
Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment (English)
1 reference
1 reference
1 reference
Hagop M Kantarjian
1 reference
Carlo Gambacorti-Passerini
1 reference
Jorge Cortes
1 reference
Charles A Schiffer
1 reference
Moshe Talpaz
1 reference
Francois Guilhot
1 reference
Manisha Mone
1 reference
Charles Sawyers
1 reference
Dietger W Niederwieser
1 reference
Richard M Stone
1 reference
John Goldman
1 reference
Thomas Fischer
1 reference
Stephen G O'Brien
1 reference
Jose J Reiffers
1 reference
Tillmann Krahnke
1 reference
11 October 2007
1 reference
1 reference
111
1 reference
3
1 reference
1039-1043
1 reference
Identifiers
1 reference